Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy
Open Access
- 1 October 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (4) , 1238-1248
- https://doi.org/10.1046/j.1523-1755.2002.00579.x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial CellsHypertension, 2001
- Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery processKidney International, 2001
- Role of Apoptosis and Bcl-2/Bax in the Development of Tubulointerstitial Fibrosis during Experimental Obstructive NephropathyNephron Experimental Nephrology, 2001
- Recovery following relief of unilateral ureteral obstruction in the neonatal ratKidney International, 1999
- Hepatocyte growth factor: Mesenchymal signal for epithelial homeostasisKidney International, 1998
- Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agentsOncogene, 1998
- Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and RegenerationBiochemical and Biophysical Research Communications, 1997
- Autocrine–Paracrine Effects of Overexpression of Hepatocyte Growth Factor Gene on Growth of Endothelial CellsBiochemical and Biophysical Research Communications, 1996
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Expressions of receptor gene for hepatocyte growth factor in kidney after unilateral nephrectomy and renal injuryBiochemical and Biophysical Research Communications, 1992